![Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know](https://pub.mdpi-res.com/cancers/cancers-14-01493/article_deploy/html/images/cancers-14-01493-g003.png?1647332793)
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
![Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrgastro.2016.51/MediaObjects/41575_2016_Article_BFnrgastro201651_Fig2_HTML.jpg)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology
![Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature](https://publinestorage.blob.core.windows.net/27b21b48-4c3a-4401-a649-56be6377f5ce/jcth-10-1240-g001.jpg)
Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature
![Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells | Scientific Reports Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-81172-0/MediaObjects/41598_2021_81172_Fig1_HTML.png)
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells | Scientific Reports
![IJMS | Free Full-Text | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis IJMS | Free Full-Text | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis](https://www.mdpi.com/ijms/ijms-20-01288/article_deploy/html/images/ijms-20-01288-g001.png)
IJMS | Free Full-Text | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis
![Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrgastro.2016.51/MediaObjects/41575_2016_Article_BFnrgastro201651_Fig3_HTML.jpg)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology
![Frontiers | Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma Frontiers | Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma](https://www.frontiersin.org/files/Articles/870840/fonc-12-870840-HTML-r1/image_m/fonc-12-870840-g001.jpg)
Frontiers | Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
![The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type | Journal of Clinical Pathology The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/69/10/846/F2.large.jpg)
The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type | Journal of Clinical Pathology
![Cancers | Free Full-Text | Pathology of Combined Hepatocellular Carcinoma- Cholangiocarcinoma: An Update Cancers | Free Full-Text | Pathology of Combined Hepatocellular Carcinoma- Cholangiocarcinoma: An Update](https://www.mdpi.com/cancers/cancers-15-00494/article_deploy/html/images/cancers-15-00494-g001-550.jpg)
Cancers | Free Full-Text | Pathology of Combined Hepatocellular Carcinoma- Cholangiocarcinoma: An Update
![Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations - ScienceDirect Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821001707-fx1.jpg)
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations - ScienceDirect
![Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut](https://gut.bmj.com/content/gutjnl/71/8/1669/F2.large.jpg)
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut
Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma | PLOS ONE
![Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features | Modern Pathology Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2013.241/MediaObjects/41379_2014_Article_BFmodpathol2013241_Fig1_HTML.jpg)
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features | Modern Pathology
![Frontiers | Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma Frontiers | Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma](https://www.frontiersin.org/files/Articles/941660/fonc-12-941660-HTML/image_m/fonc-12-941660-g001.jpg)
Frontiers | Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
![Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine | Full Text Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs10020-021-00274-7/MediaObjects/10020_2021_274_Fig1_HTML.jpg)
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine | Full Text
![Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma | Journal of Biomedical Science | Full Text Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-019-0599-5/MediaObjects/12929_2019_599_Fig3_HTML.png)
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma | Journal of Biomedical Science | Full Text
![IJMS | Free Full-Text | YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role IJMS | Free Full-Text | YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role](https://www.mdpi.com/ijms/ijms-20-00638/article_deploy/html/images/ijms-20-00638-g001.png)
IJMS | Free Full-Text | YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
![How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1756231721001778-gr1.jpg)
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect
![Biomedicines | Free Full-Text | Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach Biomedicines | Free Full-Text | Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach](https://www.mdpi.com/biomedicines/biomedicines-10-01826/article_deploy/html/images/biomedicines-10-01826-g001.png)
Biomedicines | Free Full-Text | Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
![Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5548-x/MediaObjects/12885_2019_5548_Fig1_HTML.png)
Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text
![Representative scores of keratin 7 (K7) immunoexpression in cholestatic... | Download Scientific Diagram Representative scores of keratin 7 (K7) immunoexpression in cholestatic... | Download Scientific Diagram](https://www.researchgate.net/publication/353478345/figure/fig1/AS:1050014247825408@1627354313295/Representative-scores-of-keratin-7-K7-immunoexpression-in-cholestatic-diseases-of.jpg)
Representative scores of keratin 7 (K7) immunoexpression in cholestatic... | Download Scientific Diagram
![Notch signaling activation in intrahepatic cholangiocarcinoma (ICC)... | Download Scientific Diagram Notch signaling activation in intrahepatic cholangiocarcinoma (ICC)... | Download Scientific Diagram](https://www.researchgate.net/publication/323810718/figure/fig5/AS:958518333026306@1605539987730/Notch-signaling-activation-in-intrahepatic-cholangiocarcinoma-ICC-from-AKT-Yap-mice-a.jpg)
Notch signaling activation in intrahepatic cholangiocarcinoma (ICC)... | Download Scientific Diagram
![Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature - Ahmed Bakhshwin, Keith K. Lai, Alwalid Ammoun, Kenneth Friedman, Mohamed El Hag, 2023 Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature - Ahmed Bakhshwin, Keith K. Lai, Alwalid Ammoun, Kenneth Friedman, Mohamed El Hag, 2023](https://journals.sagepub.com/cms/10.1177/10668969231157775/asset/images/large/10.1177_10668969231157775-fig6.jpeg)